On Tuesday, Facebook announced the launch of a new, stripped-down global version of its Facebook Moments private photo-sharing app; almost one year after the availability of the app in the US in June 2015. The new version of the Moments app has been launched by Facebook in Europe and Canada.
According to a TechCrunch report, the key difference between the Facebook Moments app for the US market and the new version of the app for
Europe and Canada is that the new version comes without the facial recognition feature.
The US version of Facebook Moments uses facial recognition technology for grouping together the users' photos based on their friends featured in the photos.
However, since the use of the facial recognition feature in the US version of Moments app has raised privacy concerns in international markets, the feature has been removed by Facebook in the newly-launched global version of Moments app.
Revealing that the global version of Moments app has been modified to remove the facial recognition feature, Facebook told TechCrunch that the new version cannot automatically identify the people in the photos; and. As such, it groups together photos which "appear to include the same face."
On Thursday, a judge in Northern California District Court rejected a motion by Facebook for the dismissal of a lawsuit which accuses the social network of violation of user privacy via its photo-tagging feature.
By turning down Facebook's...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
During the course of a recent interview with The Verge, automaker Volvo's Trent Victor - the company's senior technical leader of crash avoidance - said that Volvo has efforts underway to introduce an autonomous driving technology better than...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
In an announcement made via a blog post published on Tuesday, Google said that it has plans...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
On Thursday, a judge in Northern California District...
On Wednesday, a newly-leaked image on Chinese...
On Wednesday afternoon, US National Highway Traffic...
In a recent report, Finnish news site Iltalehti has...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).
